Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancers|May 3, 2020
Erratum: Berndsen, R.H., et al. Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib, Cancers 2019, 11, 1878Robert H Berndsen, Nathalie Swier, Judy R van Beijnum, et al.
Cancers|December 1, 2019
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and DasatinibRobert H Berndsen, Nathalie Swier, Judy R van Beijnum, et al.
Biochemical Society Transactions|November 18, 2014
The emerging quest for the optimal angiostatic combination therapyArjan W Griffioen, Andrea Weiss, Robert H Berndsen, et al.
Scientific Reports|March 12, 2015
Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacyAndrea Weiss, Débora Bonvin, Robert H Berndsen, et al.
Scientific Reports|February 23, 2017
Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activityRobert H Berndsen, Andrea Weiss, U Kulsoom Abdul, et al.
Angiogenesis|April 6, 2017
Epigenetic approach for angiostatic therapy: promising combinations for cancer treatmentRobert H Berndsen, U Kulsoom Abdul, Andrea Weiss, et al.
Scientific Reports|September 30, 2015
A streamlined search technology for identification of synergistic drug combinationsAndrea Weiss, Robert H Berndsen, Xianting Ding, et al.
British Journal of Cancer|June 26, 2019
Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expressionRobert H Berndsen, Cédric Castrogiovanni, Andrea Weiss, et al.
Cancers|September 24, 2020
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC TreatmentJudy R van Beijnum, Andrea Weiss, Robert H Berndsen, et al.
Angiogenesis|April 1, 2015
Rapid optimization of drug combinations for the optimal angiostatic treatment of cancerAndrea Weiss, Xianting Ding, Judy R van Beijnum, et al.
Pageof 1